XML 19 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Nov. 30, 2010
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Sales and revenues $ 106,161 $ 107,025 $ 322,237 $ 308,268
Costs of goods sold 52,998 51,270 152,945 142,061
Gross profit on sales and revenues 53,163 55,755 169,292 166,207
Operating expenses:        
Research and development 27,296 28,893 74,455 72,475
Selling, general and administrative 25,807 33,026 65,271 74,425
Restructuring charges 7 146 706 1,014
Impairment loss on equity investment 0 3,208 0 3,208
Gain on equity investment 0 (249) 0 (249)
Revaluation of contingent consideration (1,110) (1,083) (1,491) (626)
Income (loss) from operations 1,163 (8,186) 30,351 15,960
Interest income 64 241 251 559
Interest expense (33) (20) (109) (114)
Other expense, net (469) (139) (425) (475)
Income (loss) before income taxes 725 (8,104) 30,068 15,930
Provision for (benefit from) income taxes 4,002 (3,530) 15,276 6,975
Net (loss) income $ (3,277) $ (4,574) $ 14,792 $ 8,955
Net (loss) income per share:        
Basic (in dollars per share) $ (0.15) $ (0.20) $ 0.65 $ 0.40
Diluted (in dollars per share) $ (0.15) $ (0.20) $ 0.63 $ 0.39
Weighted average common shares outstanding:        
Basic (in shares) 22,486 22,679 22,847 22,586
Diluted (in shares) 22,486 22,679 23,324 22,969